Cipla launches Covid-19 diagnosis test kit CIPtest Ruchika Sharma16 Dec 2020 6:56 AMCIPtest is a reliable high-performing kit that has been validated and approved by ICMR.
Cipla Settles Patent Litigation over REVLIMID Capsules with Celgene, Bristol Myers in US Ruchika Sharma12 Dec 2020 11:06 AMAs part of the settlement, the Parties will file Consent Judgments with the United States District Court for the District of New Jersey that enjoin...
COVID antibody test in 10 mins: Cipla launches Covi-G for COVID-19 rapid antibody detection Ruchika Sharma18 Nov 2020 9:32 AMMumbai: Drug major, Cipla Limited, today announced that the company signed a licensing agreement with a Belgium- based firm, Multi G for the...
Cipla says demand for Covid antiviral drug remdesivir rising sharply in India Ruchika Sharma10 Nov 2020 6:16 AMRemdesivir has become the standard of care for patients hospitalised with severe Covid-19, with more than 50 countries including the United States...
Cipla prioritizes on Digital Adoption and resilient operations to achieve sustained Growth Ruchika Sharma9 Nov 2020 6:52 AMNew Delhi: Pharma major Cipla is looking at sustaining growth through the pandemic and has decided certain priorities for the coming quarters,...
Cipla unveils Covid antibody detection kit ELIFast Ruchika Sharma29 Oct 2020 8:00 AMELIfast has been validated and approved by ICMR and the National Institute of Virology(NIV), Pune.
Cipla launches generic Idiopathic Pulmonary Fibrosis drug Nintedanib in India Ruchika Sharma21 Oct 2020 7:30 AMNew Delhi: Pharma major Cipla on Tuesday said it has launched generic Nintedanib used for the treatment of Idiopathic Pulmonary Fibrosis (IPF) under...
NPPA fixes retail price of 26 formulations; Details Farhat Nasim30 Sept 2020 10:21 AMNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
Cipla gets USFDA nod for Dimethyl Fumarate DR Capsules to treat multiple sclerosis Ruchika Sharma27 Sept 2020 4:30 AMMumbai: Drugmaker, Cipla Limited, has recently announced that the company has received final approval for its Abbreviated New Drug Application...
CDSCO commmitee nod to Cipla, Optimus phase 4 trials of COVID drug favipiravir Farhat Nasim11 Sept 2020 9:30 AMNew Delhi: Drug major Cipla Ltd and Optimus Pharma have recently secured permission from the expert's panel of Central Drugs Standard Control...
Cipla, Stempeutics join hands for critical limb ischemia treatment in India Ruchika Sharma21 Aug 2020 6:44 AMThe product is indicated for the treatment of CLI due to Buerger''s disease and atherosclerotic peripheral arterial disease, it added.
Cipla collaborating with CSIR, IICT, ICMR, Health Ministry to develop treatment for COVID-19 Ruchika Sharma6 Aug 2020 8:37 AMNew Delhi: Drug major Cipla is working with government agencies to develop a treatment for COVID-19 while ramping up the production of various...
